IL18BP and macrophage activation syndrome: Free IL-18 was shown to be highly elevated in the serum of MAS patients, a result that is in agreement with these findings, while blocking IL-18 receptor signaling attenuated the severity of MAS and IFNγ responses in IL-18BP-affected mice [61] (Figure 4).